<?php 
get_header();
?>
	<section id="primary" class="content-area">
		<main class="page-timeline">
			<section class="page-timeline-header">
				<img src="https://galtec.ar/wp-content/uploads/2023/11/Vector-timeline.png">
				<p class="breadcrumbs">
					<span><a href="https://galtec.ar/en/home/"> HOME</a></span><span class="separador"> | </span><span><a href="https://galtec.ar/en/publications-all/">PUBLICATIONS</a></span><span class="separador"> | </span><span>SELECTED </span>
				<h1>
					Major scientific findings
				</h1>
			</section>
			<section class="page-timeline-body">
					<h1 id="our-team">
						Time<span>line</span>
					</h1>
				<section class="timeline">
					<article class="left">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2023.jpg">
						</div>
						<div class="info-timeline">
							<h2>
								2023
							</h2>
							<h4>
								Targeting galectin-driven regulatory circuits in cancer and fibrosis
							</h4>
							<p class="description">
								(Mariño et al., Nature Reviews Drugs Discovery).
							</p>
							<a target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/36759557/" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="right">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2022-EN.jpg">
						</div>
						<div class="info-time-line">
							<h2>
								2022
							</h2>
							<h4>
								Gal-1 prevents plaque formation in atherosclerosis by targeting macrophages and smooth muscle cells.
							</h4>
							<p class="description">
								(Roldán Montero et al., Science Adv.).
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/35294231/" target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="left">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2021-EN.jpg">
						</div>
						<div class="info-timeline">
							<h2>
								2021
							</h2>
							<h4>
								Gal-1 serves as a therapeutic target in intestinal inflammation and colorectal cancer.
							</h4>
							<p class="description">
								(Morosi et al., Science Adv.; Cagnoni et al. PNAS).
							</p>
							<a href=" https://pubmed.ncbi.nlm.nih.gov/34144987/" target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="right">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2018-EN.jpg">
						</div>
						<div class="info-time-line">
							<h2>
								2018
							</h2>
							<h4>
								Pathogens thwart immune responses and promote invasion via induction of Gal-1.
							</h4>
							<p class="description">
								(Lujan et al., PNAS.; Poncini et al., J. Immunol.; Davicino et al., J. Immunol; Russo et al, Nat Immunol.).
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/29891717/" target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="left">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2014.jpg">
						</div>
						<div class="info-timeline">
							<h2>
								2014
							</h2>
							<h4>
								Gal-1 promotes vascularization and confers resistance to antiangiogenic therapies.
							</h4>
							<p class="description">
								(Croci et al., Cell; Croci et al., J. Exp. Med.).
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/24529377/" target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="right">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2013-1.jpg">
						</div>
						<div class="info-time-line">
							<h2>
								2013
							</h2>
							<h4>
								A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
							</h4>
							<p class="description">
								(Laderach D, Cancer Research).
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/23108139/" target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="left">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2013-2.jpg">
						</div>
						<div class="info-timeline">
							<h2>
								2013
							</h2>
							<h4>
								Gal-1 favors breast cancer metastasis via induction of regulatory T cells.
							</h4>
							<p class="description">
								(Dalotto-Moreno et al., Cancer Res.).
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/23204230/ " target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="right">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2012-1.jpg">
						</div>
						<div class="info-time-line">
							<h2>
								2012
							</h2>
							<h4>
								Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma. 
							</h4>
							<p class="description">
								(Croci et al., J. Exp. Med.)
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/23027923/" target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="left">
					<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2012-2.jpg">
						</div>
						<div class="info-timeline">
							<h2>
								2012
							</h2>
							<h4>
								Gal-1 attenuates neuroinflammation by suppressing microglia activation.
							</h4>
							<p class="description">
								(Starossom et al., Immunity).
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/22884314/ " target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="right">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2009.jpg">
						</div>
						<div class="info-time-line">
							<h2>
								2009
							</h2>
							<h4>
								Gal-1 promotes the differentiation of tolerogenic dendritic cells.
							</h4>
							<p class="description">
								(Illarregui et al., Nature Immunol.).
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/19668220/" target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="left">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2007-EN.jpg">
						</div>
						<div class="info-timeline">
							<h2>
								2007
							</h2>
							<h4>
								Gal-1 protects the fetus from immune attack during pregnancy.
							</h4>
							<p class="description">
								(Blois et al., Nature Med.).
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/18026113/" target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="right">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2007.jpg">
						</div>
						<div class="info-time-line">
							<h2>
								2007
							</h2>
							<h4>
								Gal-1 suppresses pathogenic Th1 and Th17 cells.
							</h4>
							<p class="description">
								(Toscano et al., Nature Immunol).
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/17589510/" target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="left">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/2004.jpg">
						</div>
						<div class="info-timeline">
							<h2>
								2004
							</h2>
							<h4>
								Tumors evade immune responses via secretion of Gal-1.
							</h4>
							<p class="description">
								(Rubinstein et al., Cancer Cell).
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/15050916/" target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="right">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/11/1999-EN.jpg">
						</div>
						<div class="info-time-line">
							<h2>
								1999
							</h2>
							<h4>
								Gal-1 suppresses rheumatoid arthritis by promoting apoptosis of activated T cells.
							</h4>
							<p class="description">
								(Rabinovich et al., J. Exp. Med.).
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/10430627/ " target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
					<article class="left">
						<div class="imagen">
							<img src="https://galtec.ar/wp-content/uploads/2023/10/1998-EN.jpg">
						</div>
						<div class="info-timeline">
							<h2>
								1998
							</h2>
							<h4>
								Identification, purification and characterization of Gal-1 in innate and adaptive immune cells.
							</h4>
							<p class="description">
								(Rabinovich et al., J. Immunol).
							</p>
							<a href="https://pubmed.ncbi.nlm.nih.gov/9590230/" target="_blank" class="time-line-info">
								+Info
							</a>
						</div>
					</article>
				</section>
				<section class="timeline-mobile">
				</section>
			</section>
			<section class="timeline-footer">
				<article class="contenedor-footer">
					<p>
						Please do not hesitate to request the<br> complete article from us if you need it.
					</p>
					<div>
						<a class="contact-timeline" href="https://galtec.ar/en/#contact">
							Contact us
						</a>
					</div>
				</article>
			</section>
		</main>
	</section>

<?php 
get_footer();
?>